ID   L5178Y/D
AC   CVCL_C8YF
SY   L5178YF/Act D
DR   Wikidata; Q123032886
RX   PubMed=4321087;
CC   Selected for resistance to: ChEBI; CHEBI_27666; Actinomycin D (ActD).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8YG ! L5718YF
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   PubMed=4321087;
RA   Kessel D.H., Bosmann H.B.;
RT   "On the characteristics of actinomycin D resistance in L5178Y cells.";
RL   Cancer Res. 30:2695-2701(1970).
//